Personal information

Verified email addresses

Verified email domains

Parkinson's disease, Alpha-synuclein, Exosome, molecular and cellular neuroscience

Activities

Employment (6)

Fundacion Rioja Salud: Logroño, ES

2014-10-01 to present | Principal Investigator (Molecular Neurobiology)
Employment
Source: Self-asserted source
Lydia Alvarez-Erviti

University College London: London, London, GB

2011-09-01 to 2014-09-01 | Senior Research Fellow Parkinson's UK (Clinical Neuroscience)
Employment
Source: Self-asserted source
Lydia Alvarez-Erviti

University College London: London, London, GB

2009-10-01 to 2011-08-31 | Postdocoral Research Associate (Clinical Neuroscience)
Employment
Source: Self-asserted source
Lydia Alvarez-Erviti

University of Oxford: Oxford, Oxfordshire, GB

2008-01-06 to 2009-09-30 | Postdoctoral Research Associate (Physiology, Anatomy and Genetics)
Employment
Source: Self-asserted source
Lydia Alvarez-Erviti

University College London: London, London, GB

2006-09-25 to 2007-12-31 | Postdoctoral Visiting Fellow (FIS Fellowship) (Clinical Neuroscience)
Employment
Source: Self-asserted source
Lydia Alvarez-Erviti

Universidad de Navarra: Pamplona, Navarra, ES

2003-11-10 to 2006-09-24 | Postdoctoral Research Fellow (Centro de Investigación Médica Aplicada)
Employment
Source: Self-asserted source
Lydia Alvarez-Erviti

Education and qualifications (2)

Universidad de Navarra: Pamplona, Navarra, ES

1998-10-01 to 2002-10-31 | PhD (Toxicology)
Education
Source: Self-asserted source
Lydia Alvarez-Erviti

Universidad de Navarra: Pamplona, Navarra, ES

1993-10-01 to 1998-06-25 | BsC Pharmacy
Education
Source: Self-asserted source
Lydia Alvarez-Erviti

Funding (20)

Halting alpha-synuclein pathology progression to prevent Parkinson’s disease (STOP-PD)

2024-04 to 2026-03 | Award
Ministerio de Ciencia, Tecnología e Innovación (Madrid, AR)
Source: Self-asserted source
Lydia Alvarez-Erviti

Development of a genome editing tool for neurological diseases using targeted extracellular vesicles loaded with RNP complex. (DEGENEX)

2023-09 to 2027-08 | Grant
Ministerio de Ciencia, Innovación y Universidades (Madrid, ES)
Source: Self-asserted source
Lydia Alvarez-Erviti

Targeting mmu-miR-1843b-3p/hsa-miR-1843-3p to prevent dopaminergic degeneration

2023-02 to 2025-01 | Grant
Michael J. Fox Foundation (New York, US)
Source: Self-asserted source
Lydia Alvarez-Erviti

PAPEL CLAVE DE LA PROTEINA ALFA-SINUCLEINA EN LA TRANSFORMACIÓN MALIGNA DE LOS MELANOCITOS

2022-03 to 2025-03 | Grant
FEDER La Rioja (Logroño, ES)
Source: Self-asserted source
Lydia Alvarez-Erviti

Micotoxinas y Parkinson: ¿el eslabon perdido?.

2021-01 to 2023-05 | Grant
Gobierno de Navarra (Pamplona, ES)
Source: Self-asserted source
Lydia Alvarez-Erviti

Terapia personalizada con exosomas para el tratamiento de las enfermedades neurodegenerativas.

2020-01 to 2023-01 | Grant
Instituto de Salud Carlos III (Madrid, ES)
Source: Self-asserted source
Lydia Alvarez-Erviti

Exosomal delivery of shRNA minicircles to halt neurodegeneration and parkinsonian behaviour

2018-07 to 2019-07 | Grant
Michael J. Fox Foundation (New York, New York, US)
Source: Self-asserted source
Lydia Alvarez-Erviti

Papel de las micotoxinas en la patología de la enfermedad de Parkinson

2018-01 to 2020-06 | Grant
FEDER de La Rioja 2014-2020 (Logroño, ES)
Source: Self-asserted source
Lydia Alvarez-Erviti

Investigación de la aplicación de plasma atmosférico para la desinfección bacteriana en el ámbito de la alimentación y la salud

2018-01 to 2020-02 | Grant
Agencia de Desarrollo Económico de La Rioja (ADER) (Logroño, ES)
Source: Self-asserted source
Lydia Alvarez-Erviti

Relación origen-resistencia a antibióticos-patogenicidad-hospedador en Pseudomonas aeuroginosa aisladas de origen clínico y no-clínico. Nuevos tratamientos

2017-02 to 2020-02 | Grant
Instituto de Salud Carlos III (Madrid, ES)
Source: Self-asserted source
Lydia Alvarez-Erviti

Miguel Servet Fellowship

2016-02 to 2021-02 | Award
Instituto de Salud Carlos III (Madrid, ES)
Source: Self-asserted source
Lydia Alvarez-Erviti

Impact of alpha-synuclein upon miRNAs: role in Parkinson’s disease pathology and progression

2016-02 to 2019-02 | Grant
Instituto de Salud Carlos III (Madrid, ES)
Source: Self-asserted source
Lydia Alvarez-Erviti

Next-generation sequecing infrastructure upgrading at the Centro de Investigación Biomédica de la Rioja (CIBIR)

2016-01 to present | Award
Ministerio de Economía y Competitividad (Madrid, ES)
Source: Self-asserted source
Lydia Alvarez-Erviti

Modifing the exosomal release of alpha-synuclein as a potential target to prevent disease progression in Parkinson's disease.

2015-05 to 2018-01 | Grant
Parkinson's UK (London, GB)
Source: Self-asserted source
Lydia Alvarez-Erviti

: Analysis of tau release from cells in exosomes: potential role in the spread of tau pathology.

2015-03 to 2018-03 | Grant
Alzheimer's Society (London, GB)
Source: Self-asserted source
Lydia Alvarez-Erviti

Investigation of the cellular processing of alpha-synuclein

2012-10 to 2013-10 | Grant
Parkinson's UK (London, GB)
Source: Self-asserted source
Lydia Alvarez-Erviti

Further development of a systemic gene therapy treatment for Parkinson's disease.

2011-09 to 2017-04 | Award
Parkinson's UK (London, GB)
Source: Self-asserted source
Lydia Alvarez-Erviti

Post-doctoral Fellowship

2006-02 to 2007-12 | Award
Instituto de Salud Carlos III (Madrid, ES)
Source: Self-asserted source
Lydia Alvarez-Erviti

Visiting studentship

2001-05 to 2001-08 | Salary award
Fundación Empresa-Universidad, (Pamplona, ES)
Source: Self-asserted source
Lydia Alvarez-Erviti

Studetship

1999-04 to 2002-04 | Salary award
Department of Industry of the Government of Navarra. (Pamplona, ES)
Source: Self-asserted source
Lydia Alvarez-Erviti

Works (38)

Potential role of ochratoxin A in Parkinson’s disease: a systematic review of current evidence

Archives of Toxicology
2025-03-06 | Journal article
Part of ISSN: 0340-5761
Part of ISSN: 1432-0738
Contributors: M. Serrano-Civantos; E. Beraza; L. Álvarez-Erviti; A. López de Cerain; Ariane Vettorazzi
Source: Self-asserted source
Lydia Alvarez-Erviti

Gut microbiota produces biofilm-associated amyloids with potential for neurodegeneration

Nature Communications
2024-05-16 | Journal article | Author
Part of ISSN: 2041-1723
Contributors: Ariadna Fernández-Calvet; Leticia Matilla-Cuenca; Maria Izco; Susanna Navarro; Miriam Serrano; Salvador Ventura; Blesa J; Maite Herráiz; Gorka Alkorta-Aranburu; Sergio Galera et al.
Source: Self-asserted source
Lydia Alvarez-Erviti

High-Performance Liquid Chromatography–Fluorescence Detection Method for Ochratoxin A Quantification in Small Mice Sample Volumes: Versatile Application across Diverse Matrices Relevant for Neurodegeneration Research

Toxins
2024-05-03 | Journal article
Contributors: Elba Beraza; Maria Serrano-Civantos; Maria Izco; Lydia Alvarez-Erviti; Elena Gonzalez-Peñas; Ariane Vettorazzi
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Targeted Extracellular Vesicle Gene Therapy for Modulating Alpha-Synuclein Expression in Gut and Spinal Cord

Pharmaceutics
2023-04-13 | Journal article
Contributors: Maria Izco; Martin Schleef; Marco Schmeer; Estefania Carlos; Guglielmo Verona; Lydia Alvarez-Erviti
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Mask disinfection using atmospheric pressure cold plasma.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2022-08-19 | Journal article
Contributors: Sainz-García A; Paula Toledano Regalado; Ignacio Muro-Fraguas; Álvarez-Erviti L; Rodolfo Múgica-Vidal; López M; Sainz-García E; Beatriz Rojo-Bezares; Yolanda Saenz; Fernando Alba-Elías
Source: Self-asserted source
Lydia Alvarez-Erviti

The Two Faces of Exosomes in Parkinson’s Disease: From Pathology to Therapy

The Neuroscientist
2022-04 | Journal article
Part of ISSN: 1073-8584
Part of ISSN: 1089-4098
Contributors: Maria Izco; Estefania Carlos; Lydia Alvarez-Erviti
Source: Self-asserted source
Lydia Alvarez-Erviti

Impact of endolysosomal dysfunction upon exosomes in neurodegenerative diseases.

Neurobiology of disease
2022-02-03 | Journal article
Contributors: Izco M; Carlos E; Alvarez-Erviti L
Source: Self-asserted source
Lydia Alvarez-Erviti

Lack of Parkinsonian Pathology and Neurodegeneration in Mice After Long-Term Injections of a Proteasome Inhibitor in Olfactory Bulb and Amygdala.

Frontiers in aging neuroscience
2021-10-21 | Journal article
Contributors: Del Rey NL; Tiziano Balzano; Martin-Rodriguez L; Constanza Salinas-Rebolledo; Ines Trigo Damas; Alejandro Rojas Fernandez; Alvarez-Erviti L; Blesa J
Source: Self-asserted source
Lydia Alvarez-Erviti

Glial activation precedes alpha-synuclein pathology in a mouse model of Parkinson’s disease

Neuroscience Research
2021-09 | Journal article
Part of ISSN: 0168-0102
Contributors: Maria Izco; Javier Blesa; Guglielmo Verona; J Mark Cooper; Lydia Alvarez-Erviti
Source: Self-asserted source
Lydia Alvarez-Erviti

Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.

Frontiers in immunology
2021-09-01 | Journal article
Contributors: Maria Jesús Pons; Ymaña B; Mayanga-Herrera A; Yolanda Saenz; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Gemma Moncunill; Manuel Francisco Ugarte-Gil
Source: Self-asserted source
Lydia Alvarez-Erviti

Biomonitoring of Mycotoxins in Plasma of Patients with Alzheimer’s and Parkinson’s Disease

Toxins
2021-07-10 | Journal article
Contributors: Beatriz Arce-López; Lydia Alvarez-Erviti; Barbara De Santis; María Izco; Silvia López-Calvo; Maria Eugenia Marzo-Sola; Francesca Debegnach; Elena Lizarraga; Adela López de Cerain; Elena González-Peñas et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Oral subchronic exposure to the mycotoxin ochratoxin A induces key pathological features of Parkinson's disease in mice six months after the end of the treatment.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
2021-04-02 | Journal article
Contributors: Izco M; Ariane Vettorazzi; Forcen R; Blesa J; MARIA DE TORO; Alvarez-Herrera N; Cooper JM; Gonzalez-Peñas E; Adela Lopez de Cerain; Alvarez-Erviti L
Source: Self-asserted source
Lydia Alvarez-Erviti

Oral Sub-Chronic Ochratoxin a Exposure Induces Gut Microbiota Alterations in Mice

Toxins
2021-02-01 | Journal article
Contributors: María Izco; Ariane Vettorazzi; Maria de Toro; Yolanda Sáenz; Lydia Alvarez-Erviti
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

siRNA Loaded-Exosomes.

Methods in molecular biology (Clifton, N.J.)
2021-01-01 | Book chapter
Contributors: Izco M; Alvarez-Erviti L
Source: Self-asserted source
Lydia Alvarez-Erviti

Antimicrobial resistance and virulence of Pseudomonas spp. among healthy animals: concern about exolysin ExlA detection

Scientific Reports
2020-07-15 | Journal article
Contributors: Lidia Ruiz-Roldán; Beatriz Rojo-Bezares; María de Toro; María López; Paula Toledano; Carmen Lozano; Gabriela Chichón; Lydia Alvarez-Erviti; Carmen Torres; Yolanda Sáenz
Source: check_circle
Crossref

Systemic Exosomal Delivery of shRNA Minicircles Prevents Parkinsonian Pathology

Molecular Therapy
2019-12 | Journal article
Part of ISSN: 1525-0016
Contributors: María Izco; Javier Blesa; Martin Schleef; Marco Schmeer; Riccardo Porcari; Raya Al-Shawi; Stephan Ellmerich; María de Toro; Chris Gardiner; Yiqi Seow et al.
Source: Self-asserted source
Lydia Alvarez-Erviti

DJ-1 is a redox sensitive adapter protein for high molecular weight complexes involved in regulation of catecholamine homeostasis

Human Molecular Genetics
2017 | Journal article
EID:

2-s2.0-85031760184

Contributors: Piston, D.; Alvarez-Erviti, L.; Bansal, V.; Gargano, D.; Yao, Z.; Szabadkai, G.; Odell, M.; Puno, M.R.; Björkblom, B.; Maple-Grødem, J. et al.
Source: Self-asserted source
Lydia Alvarez-Erviti via Scopus - Elsevier

IGF1R deficiency attenuates acute inflammatory response in a bleomycin-induced lung injury mouse model

Scientific Reports
2017 | Journal article
EID:

2-s2.0-85021387987

Contributors: Piñeiro-Hermida, S.; López, I.P.; Alfaro-Arnedo, E.; Torrens, R.; Iñiguez, M.; Alvarez-Erviti, L.; Ruíz-Martínez, C.; Pichel, J.G.
Source: Self-asserted source
Lydia Alvarez-Erviti via Scopus - Elsevier

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Autophagy
2016 | Journal article
EID:

2-s2.0-85013763791

Contributors: Klionsky, D.J.; Abdelmohsen, K.; Abe, A.; Abedin, M.J.; Abeliovich, H.; Arozena, A.A.; Adachi, H.; Adams, C.M.; Adams, P.D.; Adeli, K. et al.
Source: Self-asserted source
Lydia Alvarez-Erviti via Scopus - Elsevier

Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting

Journal of Extracellular Vesicles
2015 | Journal article
EID:

2-s2.0-85016490706

Contributors: Wiklander, O.P.B.; Nordin, J.Z.; O'Loughlin, A.; Gustafsson, Y.; Corso, G.; Mäger, I.; Vader, P.; Lee, Y.; Sork, H.; Seow, Y. et al.
Source: Self-asserted source
Lydia Alvarez-Erviti via Scopus - Elsevier

Mitochondrial impairment increases FL-PINK1 levels by calcium-dependent gene expression

Neurobiology of Disease
2014 | Journal article
EID:

2-s2.0-84887561435

Contributors: Gómez-Sánchez, R.; Gegg, M.E.; Bravo-San Pedro, J.M.; Niso-Santano, M.; Alvarez-Erviti, L.; Pizarro-Estrella, E.; Gutiérrez-Martín, Y.; Alvarez-Barrientos, A.; Fuentes, J.M.; González-Polo, R.A. et al.
Source: Self-asserted source
Lydia Alvarez-Erviti via Scopus - Elsevier

Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice

Movement Disorders
2014 | Journal article
EID:

2-s2.0-84924536514

Contributors: Cooper, J.M.; Wiklander, P.B.O.; Nordin, J.Z.; Al-Shawi, R.; Wood, M.J.; Vithlani, M.; Schapira, A.H.V.; Simons, J.P.; El-Andaloussi, S.; Alvarez-Erviti, L.
Source: Self-asserted source
Lydia Alvarez-Erviti via Scopus - Elsevier

Implication of autophagy in parkinson's disease

Parkinson's Disease
2013 | Journal article
EID:

2-s2.0-84902185874

Contributors: González-Polo, R.A.; Fuentes, J.M.; Niso-Santano, M.; Álvarez-Erviti, L.
Source: Self-asserted source
Lydia Alvarez-Erviti via Scopus - Elsevier

Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in parkinson's disease

Cell Death and Disease
2013 | Journal article
EID:

2-s2.0-84875876495

Contributors: Alvarez-Erviti, L.; Seow, Y.; Schapira, A.H.V.; Rodriguez-Oroz, M.C.; Obeso, J.A.; Cooper, J.M.
Source: Self-asserted source
Lydia Alvarez-Erviti via Scopus - Elsevier

Exosome-mediated delivery of siRNA in vitro and in vivo

Nature Protocols
2012 | Journal article
EID:

2-s2.0-84870575710

Contributors: El-Andaloussi, S.; Lee, Y.; Lakhal-Littleton, S.; Li, J.; Seow, Y.; Gardiner, C.; Alvarez-Erviti, L.; Sargent, I.L.; Wood, M.J.A.
Source: Self-asserted source
Lydia Alvarez-Erviti via Scopus - Elsevier

Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line

Neuroscience Research
2011 | Journal article
EID:

2-s2.0-79951948479

Contributors: Alvarez-Erviti, L.; Couch, Y.; Richardson, J.; Cooper, J.M.; Wood, M.J.A.
Source: Self-asserted source
Lydia Alvarez-Erviti via Scopus - Elsevier

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

Nature Biotechnology
2011 | Journal article
EID:

2-s2.0-79953858598

Contributors: Alvarez-Erviti, L.; Seow, Y.; Yin, H.; Betts, C.; Lakhal, S.; Wood, M.J.A.
Source: Self-asserted source
Lydia Alvarez-Erviti via Scopus - Elsevier

Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission

Neurobiology of Disease
2011 | Journal article
EID:

2-s2.0-79954631518

Contributors: Alvarez-Erviti, L.; Seow, Y.; Schapira, A.H.; Gardiner, C.; Sargent, I.L.; Wood, M.J.A.; Cooper, J.M.
Source: Self-asserted source
Lydia Alvarez-Erviti via Scopus - Elsevier

The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation

Journal of Neuroinflammation
2011 | Journal article
EID:

2-s2.0-82155168545

Contributors: Couch, Y.; Alvarez-Erviti, L.; Sibson, N.R.; Wood, M.J.A.; Anthony, D.C.
Source: Self-asserted source
Lydia Alvarez-Erviti via Scopus - Elsevier

Chaperone-mediated autophagy markers in Parkinson disease brains

Archives of Neurology
2010 | Journal article
EID:

2-s2.0-78149469728

Contributors: Alvarez-Erviti, L.; Rodriguez-Oroz, M.C.; Cooper, J.M.; Caballero, C.; Ferrer, I.; Obeso, J.A.; Schapira, A.H.V.
Source: Self-asserted source
Lydia Alvarez-Erviti via Scopus - Elsevier

Lesion of the centromedian thalamic nucleus in MPTP-treated monkeys

Movement Disorders
2008 | Journal article
EID:

2-s2.0-44449118898

Contributors: Lanciego, J.L.; Rodríguez-Oroz, M.C.; Blesa, F.J.; Alvarez-Erviti, L.; Guridi, J.; Barroso-Chinea, P.; Smith, Y.; Obeso, J.A.
Source: Self-asserted source
Lydia Alvarez-Erviti via Scopus - Elsevier

Quick and simple synthesis of<sup>11</sup>C-(+)-α- dihydrotetrabenazine to be used as a pet radioligand of vesicular monoamine transporters | Síntesis rápida y simplificada de<sup>11</sup>C-(+)-α- dihidrotetrabenazina para su utilización como radioligando PET de los transportadores vesiculares de monoaminas

Revista Espanola de Medicina Nuclear
2008 | Journal article
EID:

2-s2.0-42549104658

Contributors: Quincoces Fernández, G.; Collantes, M.; Catalán, R.; Ecay, M.; Prieto, E.; Martino, E.; Blesa, F.J.; Álvarez-Erviti, L.; Areses, P.; Arbizu, J. et al.
Source: Self-asserted source
Lydia Alvarez-Erviti via Scopus - Elsevier

Use of<sup>11</sup>C-(+)-α-dihydrotetrabenazine for the assessment of dopaminergic innervation in animal models of Parkinson's disease | Utilización de la<sup>11</sup>C-(+)-α-dihidrotetrabenazina para la evaluación de la inervación dopaminérgica en modelos animales de la enfermedad de Parkinson

Revista Espanola de Medicina Nuclear
2008 | Journal article
EID:

2-s2.0-42549112709

Contributors: Collantes, M.; Peñuelas, I.; Álvarez-Erviti, L.; Blesa, J.; Martí-Climent, J.M.; Quincoces, G.; Delgado, M.; Ecay, M.; Martínez, A.; Arbizu, J. et al.
Source: Self-asserted source
Lydia Alvarez-Erviti via Scopus - Elsevier

Bone-marrow-derived cell differentiation into microglia: A study in a progressive mouse model of Parkinson's disease

Neurobiology of Disease
2007 | Journal article
EID:

2-s2.0-36148998691

Contributors: Rodriguez, M.; Alvarez-Erviti, L.; Blesa, F.J.; Rodríguez-Oroz, M.C.; Arina, A.; Melero, I.; Ramos, L.I.; Obeso, J.A.
Source: Self-asserted source
Lydia Alvarez-Erviti via Scopus - Elsevier

Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis

American Journal of Respiratory and Critical Care Medicine
2006 | Journal article
EID:

2-s2.0-33749425531

Contributors: Ewer, K.; Millington, K.A.; Deeks, J.J.; Alvarez, L.; Bryant, G.; Lalvani, A.
Source: Self-asserted source
Lydia Alvarez-Erviti via Scopus - Elsevier

Alterations induced in vitro by ochratoxin A in rat lymphoid cells

Human and Experimental Toxicology
2005 | Journal article
EID:

2-s2.0-26444442354

Contributors: Alvarez-Erviti, L.; Leache, C.; González-Peñas, E.; López De Cerain, A.
Source: Self-asserted source
Lydia Alvarez-Erviti via Scopus - Elsevier

Immunotoxic effects of ochratoxin A in wistar rats after oral administration.

Food and Chem Toxicol
2004 | Journal article
Source: Self-asserted source
Lydia Alvarez-Erviti

Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak

Lancet
2003 | Journal article
EID:

2-s2.0-0037420497

Contributors: Ewer, K.; Deeks, J.; Alvarez, L.; Bryant, G.; Waller, S.; Andersen, P.; Monk, P.; Lalvani, A.
Source: Self-asserted source
Lydia Alvarez-Erviti via Scopus - Elsevier